And then there were three: U.K. approves Moderna's COVID vaccine

But while it's authorized for use, the United Kingdom didn't place any early orders of this American coronavirus vaccine, so it won't be available to Brits until the spring.

• Jan 8, 2021

Pfizer says its vaccine seems effective vs. two COVID variants

But company says it still has to test it against a new wrinkle in one of those emerging, highly contagious variants.

• Jan 8, 2021

U.S. hits new record for COVID-19 deaths

Hospitals in Southern California are on the verge of rationing care as coronavirus deaths continue to surge across the country. Jonathan Vigliotti reports.

• Jan 7, 2021
• 01:43

Doctor on consequences of maskless protests

Dr. Leo Nissola joined Anne-Marie Green and Vladimir Duthiers to discuss the mostly maskless assault on the U.S. Capitol and the lack of a clear federal COVID-19 vaccine distribution plan.

• Jan 7, 2021
• 05:47

Why Tokyo has another COVID-19 emergency, and how it's fighting it

Japan has had relative success combatting the coronavirus, but many accuse its leader of failing to brace for the winter wave of infections - and delaying his response to it.

• Jan 7, 2021

Should pregnant women get a COVID-19 vaccine?

The CDC says pregnant women are at a significantly higher risk for severe COVID-19 illness and death compared to non-pregnant women of the same age. As vaccines roll out, many pregnant women are agonizing over whether to get it, and professional organizations and individual doctors say the benefits are very likely to outweigh the risks of COVID-19. Dr. Tara Narula reports.

• Jan 6, 2021
• 04:11

COVID-19 vaccination slow down

The federal government says it has now distributed more than 19 million COVID-19 doses, but it didn't specify how many people have actually been vaccinated. More than three weeks after the first shots were given, CDC data shows only five states have used more than 50% of the shots they've received. Manuel Bojorquez reports.

• Jan 6, 2021
• 02:58

China clamps down on city of 11 million in bid to quash COVID cluster

Highways in and out of Shijiazhuang are shut and schools are closed as millions are tested for the virus, which China has largely beaten with strict control measures.

• Jan 6, 2021

China delays WHO team's visit to probe COVID-19 origins

Foreign Ministry says China must complete unspecified "procedures and make relevant arrangements" before the long team of experts can be welcomed.

• Jan 6, 2021

Logistical issues plague vaccine rollouts

Nationwide logistical issues are bringing Operation Warp Speed to a crawl as states struggle to dole out vaccines. COVID-19 deaths continue to spike across most of the country as health care workers say they are stretched thin. David Begnaud reports.

• Jan 5, 2021
• 03:58

England enters emergency national lockdown

On the day Britain became the first to roll out the new Oxford-AstraZeneca vaccine, Prime Minister Boris Johnson returned the nation to national lockdown, closing all schools to combat spiraling coronavirus cases and hospitalizations. As Charlie D'Agata reports, a dangerous new strain of coronavirus from South Africa is causing concern among scientists.

• Jan 5, 2021
• 02:41

New COVID-19 strain appears in New York

As more Americans get sick with COVID-19, health officials are reporting that a man in New York has contracted a potentially more transmissible variant of the coronavirus first identified in the U.K. Dr. John Moore, professor of microbiology and immunology at Weill Cornell Medical College at Cornell University, joins CBSN to discuss the latest news surrounding the new variant and the lagging U.S. vaccine rollout.

• Jan 5, 2021
• 08:40

Equitable vaccine access emerges as next challenge amid slow rollout

Local leaders worry communities that lack access to pharmacy services will be left out.

• Jan 5, 2021

FDA warns of "risk" in U.K. plan to delay 2nd Pfizer vaccine shots

Facing a surge in infections, U.K. officials said the 2nd dose of the Pfizer vaccine can wait up to 12 weeks. The FDA says that decision is "not rooted solidly in the available evidence."

• Jan 5, 2021

Experts fear post-holiday COVID surge

The coronavirus outbreak in the U.S. is getting more dire by the day. Estimates show one American is dying from the virus every 30 seconds. Meanwhile, cases and hospitals are skyrocketing as experts warn the worst is yet to come as CBS News correspondents Jonathan Vigliotti and Manuel Bojorquez report. Then, Dr. Richard Besser, president and CEO of the Robert Wood Johnson Foundation and the former acting director of the CDC, joins CBSN to discuss the latest on the fight against COVID-19.

• Jan 4, 2021
• 14:23

Demand for vaccine grows amid slow rollout

With vaccinations in the U.S. far behind schedule, the FDA is considering cutting doses of the Moderna vaccine in half to double its supply and speed up distribution. Manuel Bojorquez has the latest.

• Jan 4, 2021
• 02:36

"CBS Evening News" headlines for January 4, 2021

Here's a look at the top stories making headlines on the "CBS Evening News with Norah O'Donnell."

• Jan 4, 2021
• 01:52

FDA considers cutting vaccine doses to stretch supply

So far, more than 4.5 million COVID shots have been given out — a fraction of the 20 million initially expected by the end of 2020.

• Jan 4, 2021

Small pharmacies helping vaccine distribution

Across the country, small pharmacies are quickly becoming a vital part of the COVID-19 vaccine distribution. They're stepping up to combat misinformation and administer the vaccine in areas where medical resources and accessibility is often limited. Mireya Villarreal reports from Texas.

• Jan 4, 2021
• 03:23

U.S. surgeon general on vaccinations delay

Surgeon General Dr. Jerome Adams joins "CBS This Morning" to discuss why there was a delay in COVID-19 vaccinations in the U.S.

• Jan 4, 2021
• 06:59

WorldView: U.K. judge nixes Assange extradition

A U.K. judge has rejected a request to extradite Wikileaks founder Julian Assange to the U.S. to face charges of espionage. Crews are searching for three people after a devastating landslide destroyed homes in Norway. South Korea is rethinking policy after seeing more deaths than births in 2020. Experts are concerned about India's Covax vaccine, which was approved before trials were finalized. CBS News foreign correspondent Roxana Saberi joins CBSN AM with today's headlines from around the globe.

• Jan 4, 2021
• 03:05

U.S. surpasses 350,000 coronavirus deaths

The U.S. is bracing for a post-holiday surge of COVID-19 cases, hospitalizations and deaths, as President Trump continues to downplay the severity of the virus. Dr. Ron Elfenbein joins CBSN to discuss the pandemic and why the vaccine distribution plan is lagging behind expectations.

• Jan 4, 2021
• 08:14

U.S. COVID death toll tops 350,000 as hospitals fill up

The situation at some Los Angeles County hospitals has grown so dire, the U.S. Army Corps of Engineers was called in to help.

• Jan 4, 2021

U.K. puts Oxford vaccine into action as COVID spreads fast

An 82-year-old dialysis patient and a scientist who helped develop the Oxford-AstraZeneca vaccine were among the first in the world to get the shot outside of trials.

• Jan 4, 2021

Vaccine distribution lagging in U.S.

Across the U.S., nearly 3 million doses of coronavirus vaccines have been administered thus far — nowhere close to Operation Warp Speed’s goal of administering 20 million doses by the end of 2020. U.S. infections are now over 20 million cases with over 349,000 deaths. Tom Hanson reports.

• Jan 2, 2021
• 02:29

Show More